NIH-funded research R21 grant

Developing tools to study the deadly amoeba Naegleria fowleri

Official title: Approaches for genetic manipulation of Naegleria fowleri

Funded at Clemson University · NIH-10762481 · Data updated 2026-11-12

This study is working on new ways to understand the Naegleria fowleri amoeba, which causes a serious brain infection, so that we can find better treatments for people affected by it.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionClemson University
NIH-funded
Lab location1 site (Clemson, United States)
Project startJanuary 9, 2023
Project endDecember 31, 2025
Funding year2024
Award (this year)$228,750
NIH project number5R21AI175463-02
Project IDNIH-10762481 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of Naegleria fowleri infections, particularly those exposed to warm freshwater environments.

Less likely to help

Patients who have already been diagnosed with PAM and are in advanced stages of the disease may not benefit from this research.

What this research studies

This research focuses on creating molecular tools to better understand Naegleria fowleri, the amoeba responsible for a severe brain infection called primary amebic meningoencephalitis (PAM). The researchers aim to utilize advanced techniques like RNA interference and CRISPR/Cas9 gene editing to explore gene functions in this organism. By gaining insights into how this amoeba operates at a genetic level, the research seeks to pave the way for the development of effective treatments for infections caused by this pathogen. This work is crucial as current treatment options are limited and often ineffective.

Why it matters

Potential benefit: If successful, this research could lead to the development of new therapeutic agents for treating infections caused by Naegleria fowleri.

How similar studies have gone: While research on Naegleria fowleri is limited, similar genetic manipulation approaches have shown promise in other pathogenic organisms, indicating potential for success in this area.

Where this research is happening

  • Clemson University
    Clemson, United States
    Active

Researchers

  • Principal investigator: Morris, James Culvin — Clemson University
  • Study coordinator: Morris, James Culvin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.